Kiavi Closes $350M Securitization, Nears $7B Total Issuance
Kiavi announced a $350 million rated securitization of residential transition loans, marking its sixth rated deal and...
This introduction explains the 5-year rule for Roth IRAs and how it affects qualified withdrawals and tax treatment.
21,792 articlesKiavi announced a $350 million rated securitization of residential transition loans, marking its sixth rated deal and...
As 2026 politics intensify, Trump claims the U.S. economy is the strongest in history. This article weighs the data a...
Gold has rallied about 73% over the past year as inflation jitters fade and risk-off trades surge. This report shows ...
TJX posted a strong fourth quarter ahead of expectations, yet conservative guidance sparked a pullback in shares as i...
Four dividend stocks flying under the radar are stepping into the spotlight as they lift dividends and beat Q4 estima...
Rocket Lab is shaping the small-launch landscape, and the company’s 2025 earnings story matters for investors. This g...
A small, overlooked quantum company could ride a wave of lab-to-market commercialization. This guide breaks down why ...
Portland launches a yearlong room rental pilot to test Oregon's new SRO rules. The program provides incentives to lan...
Investing in mobile infrastructure requires understanding the earnings engine behind 5G networks. This guide breaks d...
A major fund exit and shifting industry dynamics pushed acadia healthcare stock tanked into focus. This guide breaks ...
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
As Verastem prepares for its 2025 earnings outlook, investors should focus on cash runway, collaboration milestones, ...